| Epidemiology | Prevalence of 1:1000-5000 |
| Pathophysiology | Persisting embryonic trabecular pattern |
| Etiology | Amyloidosis, sarcoidosis, hemochromatosis, scleroderma |
| Clinical features | Heart failure, arrhythmias, thromboembolism |
| Treatment | Standard heart failure therapy, anticoagulation |
| Databases | OMIMOrphanetClinicalTrialsPubMed |